Dublin-based Zendra Health has reported 600 per cent annual growth, as its Navigator platform for neurodevelopmental diagnosis and treatment gains traction across Ireland, the UK and US. The company is on course to achieve €1 million in turnover this year. The company is now seeking investment to support further expansion in the UK and US.
Navigator automates ADHD, autism and other neurodevelopmental pathways, for faster, safer and more effective assessment and treatment. Zendra Health says that, by automating routine workflows, its partners have reduced wait lists by 33 per cent, optimised follow-up review times by 61 per cent, and eliminated gaps in safety monitoring.
Officially launched in early 2025, the Navigator platform connects clinicians, parents and teachers, aiming to improve the efficiency and consistency of assessments and ongoing care. The technology already supports more than 80,000 paying users across public and private healthcare systems. The platform is now operational in the United States, at two autism centres of excellence, and the company has also secured a contract with the NHS.
Neurodevelopmental
Zendra was founded in 2017 by Cork twins Thomas and David Coleman, and is focused on neurodevelopmental disorders, such as autism and ADHD.
Zendra CEO and co-founder, Thomas Coleman, said, “We are already seeing strong evidence-based outcomes from Navigator, with the potential to significantly improve the diagnostic and treatment journey for both children and adults with ADHD.
“At Zendra, our goal is to build software that goes beyond standard assessment into intelligent medication optimisation. Essentially, we’re creating a platform designed to make mental health medication management more efficient, safer, more accessible and more accurate.”
“Looking ahead, the real strength of the platform lies in its scalability and versatility. Navigator is a world-first medical-grade neurodevelopmental platform that is already being expanded into other conditions, including autism, with the potential to transform how mental health care is delivered globally,” Mr Coleman said.
